DOGS

Fassisi CanVecto 3

The rapid test to detect Anaplasma phagocytophilum antibodies, Borrelia burgdorferi antibodies and Ehrlichia canis antibodies in dogs.

Easy on-site usage, with results available within a few minutes
For serum, plasma and whole blood
All items required are included in the testkit
Storage at 2-30 degrees
Anaplasma Ab: Sensitivity 93,62%, Specificity 97,56%
Borrelia Ab: Sensitivity 95,83%, Specificit 98,08%
Ehrlichia Ab: Sensitivity 92,50%, Specificity 96,67%

Test Instruction

Further information

Anaplasma, Borrelia burgdorferi and Ehrlichia are vector-transmitted (ticks), intracellular bacteria and play a role in dogs.

Anaplasmosis: In Europe Anaplasma phagocytophilum and Anaplasma platys are found in domestic dogs. The antibodies are detected using A. phagocytophilum antigens or A. platys antigens.

Lyme borreliosis: Worldwide at least 13 genospecies belong to the Borrelia burgdorferi sensu lato (Bsl) complex. In dogs, the pathogenicity for B. burgdorferi sensu stricto has been proven. The antibodies are detected with a specific antigen mixture of surface proteins of Borrelia burgdorferi.

Ehrlichiosis: Dogs infected with Ehrlichiosis develop canine monocytic ehrlichiosis. The occurrence of infections is related to the spread of the vector R. sanguineus. The antibodies are detected using E. canis antigens.

Serology: Serological results must always be interpreted in conjunction with clinical findings. Negative test result: they do not rule out infection, as seronegative results may occur at any stage of infection. Positive test result: In the endemic area positive antibody results may be due to a previous infection.

CanVecto 3 – rapid tests against dog diseases

CanVecto 3 is a rapid test system, developed by Fassisi, to detect anti-bodies of common dog diseases and to find and initiate the optimal treatment measures within a short time. The test system CanVecto 3 reliably shows a possible infection with the following bacteria: Anaplasma phagocytophilum, Borrelia burgdorferi (Lyme) and Ehrlichia Canis. Fassisi rapid test systems are suitable for the use in a veterinary practice or clinic as well as for an on-site use at the patient’s home. Within a few minutes, the results of the taken blood or plasma samples are available.

There is, as with any other medical test systems, the possibility of a false-negative result, since in every stage of an infection seronegative results cannot be excluded. Also, false-positive results are possible, since antibodies from former and overcome diseases are indicated when in the taken sample. We recommend control tests to exclude false-negative or false-positive results.

Our Fassisi test systems should be stored between +2 °C and +30 °C, otherwise the systems’ functionality can be impaired.

Further information on CanVecto 3 test systems

Anaplasmosis and Lyme disease are transmitted by ticks and are therefore vector-based dog diseases. In many cases the disease doesn’t show any or only mild symptoms. However, sometimes both diseases can entail severe or even lethal complications.

Anaplasmosis: In Europe, the bacteria Anaplasma phagocytophilum and Anaplasma platys are found in pet dogs. Antibodies to both bacteria stems are detected by Fassisi test systems using corresponding antigens.

Lyme disease: Worldwide there are at least 13 geno species within the Borrelia burgdorferi sensu lato-complex. Within dogs, the species Borrelia burgdorferi sensu stricto is a verified pathogen. Its antibodies are detected via a specific mixture of antigens of Borrelia burgdorferi’s surface proteins.

Canine ehrlichiosis is a vector-based disease that is endemic in the tropics, the subtropics and the Mediterranean. Here, white blood cells are being infected by the bacteria Ehrlichia Canis that are carried foremostly by brown dog ticks (Rhipicephalus sanguineus).

Ehrlichiosis: Dogs infected with Ehrlichia bacteria develop a Canine monocytic ehrlichiosis. The occurrence of Ehrlichia infections correlates with the spread of its vector, the brown dog tick. Antibodies are detected by using E-Canis-antigens in our rapid test systems.